Literature DB >> 18945943

Unified criteria for ultrasonographic diagnosis of ADPKD.

York Pei1, James Obaji, Annie Dupuis, Andrew D Paterson, Riccardo Magistroni, Elizabeth Dicks, Patrick Parfrey, Benvon Cramer, Eliecer Coto, Roser Torra, Jose L San Millan, Robert Gibson, Martijn Breuning, Dorien Peters, David Ravine.   

Abstract

Individuals who are at risk for autosomal dominant polycystic kidney disease are often screened by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. Families with mutations in PKD2 typically have less severe disease, suggesting a potential need for different diagnostic criteria. In this study, 577 and 371 at-risk individuals from 58 PKD1 and 39 PKD2 families, respectively, were assessed by renal ultrasound and molecular genotyping. Using sensitivity data derived from genetically affected individuals and specificity data derived from genetically unaffected individuals, various diagnostic criteria were compared. In addition, data sets were created to simulate the PKD1 and PKD2 case mix expected in practice to evaluate the performance of diagnostic criteria for families of unknown genotype. The diagnostic criteria currently in use performed suboptimally for individuals with mutations in PKD2 as a result of reduced test sensitivity. In families of unknown genotype, the presence of three or more (unilateral or bilateral) renal cysts is sufficient for establishing the diagnosis in individuals aged 15 to 39 y, two or more cysts in each kidney is sufficient for individuals aged 40 to 59 y, and four or more cysts in each kidney is required for individuals > or = 60 yr. Conversely, fewer than two renal cysts in at-risk individuals aged > or = 40 yr is sufficient to exclude the disease. These unified diagnostic criteria will be useful for testing individuals who are at risk for autosomal dominant polycystic kidney disease in the usual clinical setting in which molecular genotyping is seldom performed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945943      PMCID: PMC2615723          DOI: 10.1681/ASN.2008050507

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease.

Authors:  York Pei
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

2.  Is there a third gene for autosomal dominant polycystic kidney disease?

Authors:  A D Paterson; Y Pei
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

3.  Somatic inactivation of Pkd2 results in polycystic kidney disease.

Authors:  G Wu; V D'Agati; Y Cai; G Markowitz; J H Park; D M Reynolds; Y Maeda; T C Le; H Hou; R Kucherlapati; W Edelmann; S Somlo
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Kyongtae T Bae; Sandro Rossetti; Vicente E Torres; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Philip J Kenney; Mark Consugar; Saulo Klahr; William M Bennett; Catherine M Meyers; Qin Jean Zhang; Paul A Thompson; Fang Zhu; J Philip Miller
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

5.  Familial phenotype differences in PKD11.

Authors:  N Hateboer; L P Lazarou; A J Williams; P Holmans; D Ravine
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

6.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

7.  Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.

Authors:  N Hateboer; M A v Dijk; N Bogdanova; E Coto; A K Saggar-Malik; J L San Millan; R Torra; M Breuning; D Ravine
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

8.  Evidence for a third genetic locus for autosomal dominant polycystic kidney disease.

Authors:  M C Daoust; D M Reynolds; D G Bichet; S Somlo
Journal:  Genomics       Date:  1995-02-10       Impact factor: 5.736

9.  The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.

Authors:  J Hughes; C J Ward; B Peral; R Aspinwall; K Clark; J L San Millán; V Gamble; P C Harris
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

10.  Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Authors:  Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul A Thompson; J Philip Miller; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

View more
  227 in total

Review 1.  The living kidney donor evaluation: focus on renal issues.

Authors:  Ajay Kher; Didier A Mandelbrot
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

2.  Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Authors:  Giorgina B Piccoli; Vincenzo Arena; Valentina Consiglio; Maria Chiara Deagostini; Ettore Pelosi; Anastasios Douroukas; Daniele Penna; Giancarlo Cortese
Journal:  BMC Nephrol       Date:  2011-09-29       Impact factor: 2.388

Review 3.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 4.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

5.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

Review 6.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

7.  The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.

Authors:  Emilie Cornec-Le Gall; Fouad T Chebib; Charles D Madsen; Sarah R Senum; Christina M Heyer; Brendan C Lanpher; Marc C Patterson; Robert C Albright; Alan S Yu; Vicente E Torres; Peter C Harris
Journal:  Am J Kidney Dis       Date:  2018-02-01       Impact factor: 8.860

8.  Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.

Authors:  Masahiko Oguro; Yuta Kogure; Junichi Hoshino; Yoshifumi Ubara; Hiroki Mizuno; Akinari Sekine; Masahiro Kawada; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Tatsuya Suwabe; Naoki Sawa; Kenmei Takaichi
Journal:  J Nephrol       Date:  2018-10-24       Impact factor: 3.902

Review 9.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

10.  Family history of renal disease severity predicts the mutated gene in ADPKD.

Authors:  Moumita Barua; Onur Cil; Andrew D Paterson; Kairon Wang; Ning He; Elizabeth Dicks; Patrick Parfrey; York Pei
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.